Removal and prevention of dental plaque with D-tagatose

International Journal of Cosmetic Science

Volumn 24, Issue 4, 2002, Pages 225-234

  Lu, Y ^a   Levin, G V ^a  

^a Spherix Incorporated   (United States)

Author keywords

Biofilm; D tagatose; Dental plaque; Microbial coaggregation

Indexed keywords

GALACTOSE; SORBITOL; TAGATOSE; TOOTHPASTE;

ACTINOBACILLUS; ACTINOMYCES; ARTICLE; BACTERIAL COLONIZATION; BIOFILM; CAPNOCYTOPHAGA; CONTROLLED STUDY; FUSOBACTERIUM; GINGIVA DISEASE; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS; PREVOTELLA; SALIVA; STREPTOCOCCUS; TOOTH PLAQUE; VEILLONELLA;

EID: 0036997321     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1467-2494.2002.00141.x     Document Type: Article

References (49)

1. Kolenbrander, P.E. Oral microbial communities. bio-films, interactions, and genetic systems. Annu. Rev. Microbiol. 54,413-437 (2000).
2. Moore, W.E. and Moore, L.V. The bacteria of periodontal diseases. Periodontol. 2000 5,66-77 (1994).
3. Beck, J.D., Koch, G.G., Zambon, J.J., Genco, R.J. and Tudor, G.E. Evaluation of oral bacteria as risk indicators for periodontitis in older adults. J. Periodontol. 63,93-99 (1992).
4. Bolstad, A.I., Jensen, H.B. and Bakken, V. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin. Microbiol. Rev. 9,55-71 (1996).
5. Haffajee, A.D. and Socransky, S.S. Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000(5),78-111 (1994).
6. Socransky, S.S., Haffajee, A.D., Cugini, M.A., Smith, C. and Kent R.L. Jr. Microbial complexes in subgingi valplaque. J. Clin. Periodontol. 25,134-144 (1998).
7. Kolenbrander, P.E. and London, J. Adhere today, here tomorrow: oral bacterial adherence. J. Bacteriol. 175,3247-3252 (1993).
8. Christersson, L.A., Zambon, J.J. and Genco, R.J. Dental bacterial plaques: nature and role in periodontal disease. J. Clin. Periodontol. 18,441-446 (1991).
9. Hardie, J.M. Oral microbiology: current concepts in the microbiology of dental caries and periodontal disease. Br. Dent. J. 172,271-278 (1992).
10. Kinder, S.A. and Holt, S.C. Characterization of coaggregation between Bacteroides gingivalis T22 and Fusobacterium nucleatum T18. Infect. Immun. 57,3425-3433 (1989).
11. Kolenbrander, P.E. and Andersen, R.N. Inhibition of coaggregation between Fusobacterium nucleatum and Porphyromonas (Bacteroides) gingivalis by lactose and related sugars. Infect. Immun. 57,3204-3209 (1989).
12. Kolenbrander, P.E. and Andersen, R.N. Multigeneric aggregations among oral bacteria: a network of independent cell-to-cell interactions. J. Bacteriol. 168,851-859 (1986).
13. Kolenbrander, P.E., Andersen, R.N. and Moore, L.V. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect. Immun. 57,3194-3203 (1989).
14. Kolenbrander, P.E., Parrish, K.D., Andersen, R.N. and Greenberg, E.P. Intergeneric coaggregation of oral Treponema spp. with Fusobacterium spp. & intrageneric coaggregation among Fusobacterium spp. Infect. Immun. 63,4584-4588 (1995).
15. Shaniztki, B., Hurwitz, D., Smorodinsky, N., Ganeshkumar, N. and Weiss, E.I. Identification of a Fusobacterium nucleatum PK1594 galactose-binding adhesin which mediates coaggregation with periopathogenic bacteria and hemagglutination. Infect. Immun. 65,5231-5237 (1997).
16. De Boever, E.H. and Loesche, W.J. Assessing the contribution of anaerobic microflora of the tongue to oral malodor. J. Am. Dent. Assoc. 126,1384-1393 (1995).
17. Quirynen, M., Van Eldere, J., Pauwels, M., Bollen, C.M. and van Steenberghe, D. In vitro volatile sulfur compound production of oral bacteria in different culture media. Quintessence Int. 30,351-356 (1999).
18. Waler, S.M. On the transformation of sulfur-containing amino acids and peptides to volatile sulfur compounds (VSC) in the human mouth. Eur. J. Oral Sci. 105, 534-537 (1997).
19. Yaegaki, K. and Sanada, K. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. J. Periodontal. Res. 27, 233-238 (1992).
20. Moore, W.E., Holdeman, L.V., Cato, E.P., Smibert, R.M., Burmeister, J.A. and Ranney, R.R. Bacteriology of moderate (chronic) periodontitis in mature adult humans. Infect. Immun. 42,510-515 (1983).
21. Moore, L.V., Moore, W.E., Cato, E.P., et al. Bacteriology of human gingivitis. J. Dent. Res. 66,989-995 (1987).
22. Dzink, J.L., Socransky, S.S. and Haffajee, A.D. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J. Clin. Periodontol. 15,316-323 (1988).
23. Moore, W.E., Holdeman, L.V., Cato, E.P., et al. Comparative bacteriology of juvenile periodontitis. Infect. Immun. 48,507-519 (1985).
24. Kolenbrander, P.E., Ganeshkumar, N., Cassels, F.J. and Hughes, C.V. Coaggregation: specific adherence among humanoral plaque bacteria. FASEB J. 7,406-413 (1993).
25. Kolenbrander, P.E. Coaggregations among oral bacteria. Meth. Enzymol. 253,385-397 (1995).
26. Shaniztki, B., Ganeshkumar, N. and Weiss, E.I. Characterization of a novel N-acetylneuraminic acid-specific Fusobacterium nucleatum PK1594 adhesin. Oral Microbiol. Immunol. 13,47-50 (1998).
27. Weiss, E.I., London, J., Kolenbrander, P.E., Kagermeier, A.S. and Andersen, R.N. Characterization of lectinlike surface components on Capnocytophaga ochracea ATCC 33596 that mediate coaggregation with Gram-positive oral bacteria. Infect. Immun. 55,1198-1202 (1987).
28. Spherix press release. Tagatose gets green light: expert panel finds sweetener 'GRAS', Arla Foods moves forward on commercialization plans. April11, (2001).
29. Lu, Y. D-Tagatose, a novel humectant sweetener for toothpastes. Cosmet. Toiletries 116,95-100 (2001).
30. Lu, Y. Humectancies of D-tagatose and D-sorbitol. Int. J. Cosmetic Sci. 23,175-181 (2001).
31. Cisar, J.O., Kolenbrander, P.E. and McIntire, F.C. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect. Immun. 24,742-752 (1979).
32. Kolenbrander, P.E., Inouye, Y. and Holdeman, L.V. New actinomyces and streptococcus coaggregation groups among human oral isolates from the same site. Infect. Immun. 41,501-506 (1983).
33. Weiss, E.I., Shaniztki, B., Dotan, M., Ganeshkumar, N., Kolenbrander, P.E. and Metzger, Z. Attachment of Fuso-bacterium nucleatum PK1594 to mammalian cells and its coaggregation with periodontopathogenic bacteria are mediated by the same galactose-binding adhesin. Oral Microbiol. Immunol. 15,371-377 (2000).
34. Kolenbrander, P.E. and Andersen, R.N. Intergeneric rosettes: sequestered surface recognition among human periodontal bacteria. Appl. Environ. Microbiol. 54,1046-1050 (1988).
35. Causton, B.E. Prevention of undesired adsorption on surfaces. US Patent 4,663,202. National Research Development Corporation, London, UK (1987).
36. Degenhardt, C.R., Kozikowski, B.A. Oral compositions. US Patent 4,877,603. The Procter & Gamble Company, OH (1989).
37. Au, V., Carson, R.G., Harirchian, B. and Schilling, K.M. Oral hygiene compositions containing amino sugars as antiplaque agents. US Patent 5,362,480. Lever Brothers Company, Division of. Conopco Inc, NewYork, NY (1994).
38. Au, V., Carson, R.G., Harirchian, B. and Schilling, K.M. Oral hygiene compositions containing antiplaque agents. US Patent 5,310,542. Lever Brothers Company, Division of Conopco Inc, NewYork, NY (1994).
39. Gaffar, A., Gibbons, R.J. and Tylewksa, S. Oligosaccharide Inhibition of Streptococcus Pyogenes adhesion. US Patent 5,002,759. Colgate-Palmolive Company, NJ and Forsyth Dental Center, MA (1991).
40. Neeser, J.R. Dental anti-plaque and anti-caries agent. US Patent 4,994,441. Nestec S.A., Vevey, Switzerland (1991).
41. Neeser, J.R. Dentalanti-plaque and anti-caries agent. US Patent 4,992,420. Nestec S.A, Vevey, Switzerland (1991).
42. Weiss, E.I., Lev-Dor, R., Kashamn, Y., Goldhar, J., Sharon, N. and Ofek, I. Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent. J. Am. Dent. Assoc. 129,1719-1723 (1998).
43. Weiss, E., Ofek, I., Kashman, Y., Goldhar, J. and Sharon, N. Anti-oral-microbial adhesion fraction derived from vaccinium. US Patent 5,840,322. Ramot-University Authority for Applied Research & Industrial Devel Ltd., Israel (1998).
44. Murray, P.A., Kern, D.G. and Winkler, J.R. Identification of a galactose-binding lectin on Fusobacterium nucleatum FN-2. Infect. Immun. 56,1314-1319 (1988).
45. Levin, G.V., Zehner, L.R., Saunders, J.P. and Beadle, J.R. Sugar substitutes: their energy values, bulk characteristics, and potential health benefits. Am. J. Clin. Nutr. 62(Suppl.),1161S-1168S (1995).
46. Beadle, J.R., Saunders, J.P. and Wajda, T.J. Process for manufacturing tagatose. US Patent 5,078,796. Biospherics Inc, Maryland (1992).
47. Beadle, J.R., Saunders, J.P. and Wajda, T.J. Process for manufacturing tagatose. US Patent 5,002,612. Biospherics Inc, Maryland (1991).
48. Wu, T., Trevisan, M., Genco, R.J., Falkner, K.L., Dorn, J.P. and Sempos, C.T. Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am. J. Epidemiol. 151,273-282 (2000).
49. Andersen, H. and Vigh, M.L. Use of D-tagatose as synergiser and flavor enhancer. European Patent WO 9,934,689. MD Foods A.M.B.A. (1999).